Related by context. All words. (Click for frequent words.) 67 MOZOBIL 66 maribavir 66 SEBIVO 66 clofarabine 66 Mepact 65 Civacir 64 Velcade bortezomib 64 Evoltra 64 Firazyr 64 Marqibo 63 Fodosine 63 Evoltra TM 63 Cimzia 63 pralatrexate 63 Evoltra ® 63 G CSF 63 sumatriptan DosePro 63 Dacogen 63 Jevtana 62 MyVax R 62 Noxafil 62 Campath alemtuzumab 62 Dacogen injection 62 Treanda 62 TEMODAL 62 HuMax CD4 62 CoFactor 62 Increlex ® 62 Zavesca r 62 Evoltra R 62 VEGF Trap 62 Ceflatonin 62 Amrubicin 62 Davanat 62 Personalized Immunotherapy 62 Icatibant 62 Vidaza 62 Phase IIIb clinical 62 Clolar ® 62 Clolar 62 Vandetanib 62 eltrombopag 62 PrevOnco ™ 61 OncoVEX 61 OncoGel 61 relapsed multiple myeloma 61 Advagraf 61 Nexavar ® 61 sunitinib malate 61 Cardio Vascu Grow 61 Certican 61 Thymoglobulin 61 AzaSite Plus 61 ixabepilone 61 BAY #-# 61 Alvesco R 61 Omapro 61 YONDELIS 61 Camvia 61 MabCampath 61 Revlimid lenalidomide 61 TRISENOX 61 PROMACTA 61 Privigen 61 Nebido 61 obatoclax 61 Folotyn 61 LEUKINE 61 anidulafungin 61 Ixempra 61 Combidex 61 registrational 61 StaphVAX 61 pegfilgrastim 60 histamine dihydrochloride 60 valopicitabine 60 hoFH 60 Advexin 60 MEPACT 60 oral ridaforolimus 60 carfilzomib 60 Loramyc R 60 Allovectin 7 60 Promacta 60 REPEL CV 60 Cx# [002] 60 StemEx R 60 omacetaxine mepesuccinate 60 Vasovist 60 THALOMID 60 Soliris TM eculizumab 60 BrachySil TM 60 Cloretazine R VNP#M 60 Arcalyst 60 Ceplene 60 Replagal 60 trastuzumab Herceptin 60 panitumumab 60 Acapodene 60 lumiliximab 60 palifermin 60 Onco TCS 60 Arzerra 60 Filgrastim 60 Azedra 60 Synvisc One 60 NEBIDO 60 Lumacan 60 glufosfamide 60 Herceptin trastuzumab 60 TREANDA 60 TroVax ® 60 orBec 60 Abraxane 60 tamibarotene 60 OHR/AVR# 60 TYZEKA 60 Onconase 60 Loramyc 60 Renvela 60 Leukine 60 Campath 60 omacetaxine 60 cetuximab Erbitux ® 60 elotuzumab 60 EndoTAG TM -1 59 Bendamustine 59 BioSTAR R 59 SNT MC# 59 intravenous acetaminophen 59 Pertuzumab 59 TELINTRA 59 Aviptadil 59 phase IIa clinical 59 investigational monoclonal antibody 59 ruxolitinib 59 Clofarabine 59 thymalfasin 59 velaglucerase alfa 59 Insegia 59 Aloxi injection 59 Torisel 59 ProSavin 59 Marketing Authorization Application 59 Corlux 59 Ruconest 59 Teysuno 59 Troxatyl 59 liprotamase 59 MONOVISC 59 sargramostim 59 Somatuline Depot 59 Raptiva ® 59 ofatumumab 59 Zingo TM 59 Promus Element stent 59 rilonacept 59 Xcellerated T Cells 59 Voraxaze 59 Iluvien ® 59 NPSP# 59 oral deforolimus 59 TheraCIM 59 VELCADE 59 Nexavar sorafenib 59 Campath ® 59 Orathecin 59 ambrisentan 59 Urocidin 59 R sorafenib tablets 59 vorinostat 59 JAK inhibitor 59 Allovectin 7 ® 59 IMA# 59 OPAXIO 59 Nplate 59 phase IIb trial 59 Excellagen 59 Genentech Roche 59 Vectibix panitumumab 59 TG# [003] 59 neratinib 59 Taxotere ® 59 Phase Ib study 59 proteasome inhibitor 59 Dacogen decitabine 59 enzastaurin 59 MyVax ® 59 DXL# 59 HuLuc# 59 corticosteroid dexamethasone 59 Prednisporin TM 59 methylnaltrexone 59 Amigal 59 iclaprim 59 oral fludarabine 59 filgrastim 59 BENLYSTA 59 Telatinib 59 Panzem 59 Neurostep TM 59 NOXAFIL 59 Neulasta ® 59 sNDA filing 59 ezogabine 59 alemtuzumab Campath 59 octreotide implant 59 ONTAK 59 Golimumab 59 Exforge 59 cancer immunotherapies 59 deforolimus 59 Kuvan 59 Cimzia ® 59 LAF# 59 FOLOTYN 59 Cellegesic 59 TOCOSOL Camptothecin 59 tafamidis 59 multiple myeloma MM 59 OncoVEX GM CSF 59 ADVEXIN 59 tanespimycin 59 oxypurinol 59 GTC recombinant human 59 basiliximab 59 rhC1INH 59 Zavesca 59 Octreotide 59 Genasense 59 PLK1 SNALP 59 Taxotere docetaxel 59 Plenaxis TM 59 MyVax 58 Zelrix 58 OncoVex 58 Loramyc ® 58 amrubicin 58 Zenapax 58 Targretin capsules 58 Onrigin 58 L BLP# 58 Tarceva TM 58 BLA filing 58 rhThrombin 58 Gliadel Wafer 58 oral methylnaltrexone 58 Increlex 58 VPRIV 58 HuMax CD# 58 chemotherapy induced neutropenia 58 Phenoptin 58 Tekamlo 58 trastuzumab DM1 58 Plicera 58 monoclonal antibody therapies 58 daclizumab 58 subcutaneous formulation 58 investigational therapies 58 brentuximab 58 CD# antibody [001] 58 ISF# 58 Rhucin 58 lintuzumab 58 Increlex R 58 pemetrexed Alimta 58 Multiferon R 58 PROCHYMAL 58 Gleevec imatinib mesylate 58 VitiGam 58 GEM #S 58 bendamustine 58 mertansine 58 entinostat 58 Teflaro 58 OvaRex ® MAb 58 Fludara 58 Reolysin 58 dirucotide 58 ALN RSV# 58 Lupuzor 58 Vascular Wrap TM 58 Hycamtin 58 Velcade 58 FOLOTYN ® 58 Sebivo 58 Annamycin 58 reslizumab 58 Phase #/#a trial 58 Allovectin 7 R 58 TroVax 58 rALLy clinical trial 58 QVAR 58 MoxDuo IR 58 Ketotransdel 58 orphan designation 58 Specifid 58 Removab 58 HQK 58 StemEx 58 ONCASPAR 58 OZURDEX ® 58 sorafenib tablets 58 refractory chronic lymphocytic 58 SIR Spheres 58 Everolimus 58 personalized immunotherapy 58 phase IIb clinical 58 PREOS R 58 pomalidomide 58 ALN PCS 58 Pegintron 58 lapatinib Tykerb 58 EOquin 58 XmAb# 58 dasatinib Sprycel 58 docetaxel Taxotere 58 ORENCIA R 58 Kepivance 58 indolent NHL 58 Fortigel 58 ponatinib 58 zanolimumab 58 PREOS 58 MAGE A3 ASCI 58 Numax 58 Raptiva R 58 Myocet 58 PrevOnco 58 Bronchitol 58 LBH# 58 DepoDur 58 CINTREDEKIN BESUDOTOX 58 Mipomersen 58 targeted antifolate 58 INCB# [001] 58 Gleevec resistant 58 Aclasta Reclast 58 Tarceva erlotinib 58 Levoleucovorin 58 ITAX 58 cinacalcet HCl 58 Cloretazine ® 58 TOCOSOL Paclitaxel 58 Amevive 58 Orphan Drug Status 58 Romiplostim 58 therapeutic regimens 58 HepeX B 58 LHRH antagonist 58 CytoFab 58 MethyPatch 58 Esbriet 58 Pulminiq 58 relapsed ovarian cancer 58 Firdapse 58 Theratope 57 Ontak 57 Eliquis 57 Asentar 57 Gleevec Glivec 57 Phase Ib clinical 57 DAVANAT ® 57 Relistor 57 YERVOY 57 plerixafor 57 alvespimycin 57 Cladribine 57 Virulizin R 57 Generx ™ 57 Somatuline Autogel 57 WILEX 57 Revlimid 57 bortezomib Velcade 57 CHOP chemotherapy 57 FavId 57 bevacizumab Avastin 57 chronic angina 57 MYDICAR 57 mifamurtide 57 AEG# 57 Nicole Onetto MD 57 ofatumumab HuMax CD# 57 pertuzumab 57 liposomal doxorubicin 57 dacetuzumab 57 Zirgan 57 T Pred 57 Zolinza 57 Antegren 57 Sym# 57 Tykerb lapatinib 57 systemic immunosuppressive drugs 57 zileuton CR 57 Alemtuzumab 57 immunosuppressant drug 57 OMNARIS 57 Excellarate 57 tezampanel 57 etanercept Enbrel 57 Degarelix 57 LidoPAIN SP 57 Proxinium TM 57 Arzerra ofatumumab 57 Erbitux cetuximab 57 rThrombin 57 CR# vcMMAE 57 Irinotecan 57 Emselex 57 Catena ® 57 PEG SN# 57 RLY# 57 amifampridine phosphate 57 trabectedin 57 romiplostim 57 Tavocept 57 MBP# [001] 57 tremelimumab 57 ketolide antibiotic 57 vidofludimus 57 Santhera 57 Saforis 57 Benlysta belimumab 57 TAXUS Element Stent System 57 docetaxel Taxotere ® 57 Actemra tocilizumab 57 custirsen 57 elacytarabine 57 CTAP# Capsules 57 BiovaxID 57 INTEGRILIN ® 57 novel oral anticoagulant 57 ® bortezomib 57 alogliptin 57 Zybrestat 57 Cimzia TM 57 standard chemotherapy regimen 57 ularitide 57 vandetanib 57 docetaxel Taxotere R 57 Zytiga 57 PTK ZK 57 prGCD 57 Cloretazine 57 FTY# 57 DYNEPO 57 EFAPROXYN 57 AQ4N 57 Plenaxis R 57 dalbavancin 57 TELCYTA 57 Hectorol 57 Sutent sunitinib 57 DCVax R Brain 57 orBec R 57 Avastin bevacizumab 57 Augment Bone Graft 57 IMGN# 57 Rituxan rituximab 57 azacitidine 57 BEXXAR 57 Satraplatin 57 ELAPRASE 57 Navelbine ® 57 Recothrom 57 Firazyr ® 57 ONGLYZA ™ 57 BEMA Fentanyl 57 BST CarGel R 57 Xanafide 57 MAA submission 57 Flutiform TM 57 Xcytrin 57 Arranon 57 Uplyso 57 MGd 57 SEPET 57 Archexin 57 investigational antiplatelet agent 57 incyclinide 57 calcineurin inhibitors 57 DPX Survivac 57 Durezol 57 Neuvenge 57 VALSTAR 57 ocular formulation 57 RhuDex ® 57 AP# [003] 57 Veronate 57 DC Bead 57 DAVANAT R 57 IV Busulfex 57 anti EGFR antibody 57 Virulizin ® 57 acyclovir Lauriad R 57 Mycamine 57 relapsed refractory aggressive 57 Surfaxin LS 57 romidepsin 57 therapeutic monoclonal antibody 57 liposomal formulation 57 vemurafenib 57 metastatic hormone refractory 57 Factor VIIa 57 Omigard 57 Cethrin 57 telbivudine 57 radiation sensitizer 57 HuMax TAC 57 Phase 2b trial 57 Augment Injectable 57 OvaRex R 57 Acetavance 57 Leukine ® 57 ClearPath HDR 57 AZILECT ® 57 HGS# 57 HCV protease inhibitors 57 tezampanel NGX# 57 generation purine nucleoside 57 sorafenib Nexavar 57 Neoral 57 RECOTHROM R 57 Amplimexon 57 Zerenex 57 Phase IIa trial 57 phase IIb III 57 imatinib Gleevec 57 abiraterone acetate 57 Rescula 57 Interferon Alpha 57 Orphan Drug designation 57 refractory CLL 57 Alnara 57 Telavancin 57 Trofex 57 Exalgo 57 ADVEXIN p# therapy 57 Dendreon Provenge 57 MAXY VII 57 INTERCEPT platelets 56 Biologics License Application 56 Bayer Nexavar 56 Phase 1b trial 56 regorafenib 56 Centralized Procedure 56 BENLYSTA ® 56 Nivestim 56 Intravenous CP 56 Phase Ib 56 IMC #B 56 nalbuphine ER 56 targeted radiotherapeutic 56 severe hypercholesterolemia 56 Pfizer Sutent 56 rituximab Rituxan 56 EndoTAG TM 56 Cumulase 56 Vidaza azacitidine 56 ganetespib 56 TORISEL 56 Omacetaxine 56 MyVax personalized immunotherapy 56 SUTENT 56 TRISENOX ® 56 Phase III clinical 56 axitinib 56 Neo Bladder Augment 56 lomitapide 56 Pirfenidone 56 Sprycel 56 Pegasys peginterferon alfa 2a 56 T DM1 56 Pixantrone 56 Mycograb 56 Junovan 56 Actimmune ® 56 Vfend 56 tivozanib 56 Imprime PGG 56 Provenge prostate cancer 56 Dapagliflozin 56 G#DT 56 Oncophage 56 refractory Hodgkin lymphoma 56 sapacitabine 56 EOquin TM 56 Zarnestra 56 ATG Fresenius S 56 CONBRIZA 56 Diamyd ® 56 alvimopan 56 Sulonex TM 56 HEPLISAV 56 calcineurin inhibitor 56 Soliris eculizumab 56 Targretin 56 KNS # 56 budesonide foam 56 UPLYSO 56 IND submission 56 Afinitor 56 cystinosis patients 56 registrational trial 56 Hexvix 56 DAVANAT 56 Menveo 56 Traficet EN 56 REPLAGAL 56 Fusilev 56 pegylated interferon alfa 56 ospemifene 56 CMV vaccine 56 ATryn R 56 Bicifadine 56 NV1FGF 56 Topical Interferon Alpha 2b 56 Levadex 56 Onalta ™ 56 SYCREST 56 Macroplastique 56 AzaSite 56 MK #B 56 Thrombin 56 VIDAZA 56 forodesine 56 Fibrillex TM 56 samalizumab 56 Pemetrexed 56 Gleevec imatinib 56 Fabry Disease 56 relapsed MM 56 dermaPACE TM 56 motesanib 56 Genz # 56 Orphan Drug Designation 56 Revimmune 56 Elotuzumab 56 refractory metastatic colorectal cancer 56 Tocosol Paclitaxel 56 Zenpep 56 PEG Interferon lambda 56 DiabeCell ® 56 initiate Phase Ib 56 Daclizumab 56 Octreolin 56 Frova ® 56 CEQ# 56 danoprevir 56 peginesatide 56 #D#C# 56 Zavesca R 56 pain palliation 56 Alzhemed TM 56 IMiDs 56 Onbrez Breezhaler 56 ALN TTR# 56 ImClone Erbitux 56 ProLindac 56 Aryplase 56 ZOLINZA 56 Spiegelmer ® 56 Vimpat ® lacosamide 56 refractory acute myeloid 56 Viramidine 56 RANK Ligand inhibitor 56 refractory angina 56 Neupro 56 PLX# 56 BRAF inhibitor 56 diabetic neuropathic pain 56 Dyloject TM 56 Mylotarg 56 ZENPEP 56 gastrointestinal stromal tumors 56 MEZAVANT 56 eniluracil 56 Cinryze ™ 56 relapsed refractory 56 PEG PAL 56 ROTATEQ 56 talactoferrin 56 Cinquil 56 Xyotax 56 Ocrelizumab 56 ELACYT 56 Symadex 56 paclitaxel Taxol ® 56 Mimpara 56 TASKi3 56 Nabi HB Intravenous 56 Votrient 56 Celgene Revlimid 56 Zadaxin 56 FVIIa 56 HspE7 56 CNTO 56 docetaxel chemotherapy 56 Telcyta 56 hA# 56 Multiferon 56 tolevamer 56 Vicinium TM 56 oropharyngeal candidiasis 56 IAP inhibitors 56 MabThera Rituxan 56 ATIR TM 56 TBC# 56 UCB Cimzia 56 Myfortic 56 BNC# 56 Japanese Encephalitis vaccine 56 Levulan PDT 56 RSR# 56 balsalazide tablet 56 adalimumab Humira 56 GA GCB 56 herpetic keratitis 56 cangrelor 56 ZEFTERA TM Zevtera TM 56 Dalbavancin 56 milatuzumab 56 Ilaris 56 Laquinimod 56 thalidomide Thalomid 56 PSMA ADC 56 drug ISA# 56 IRX 2 56 Virulizin 56 Chemophase 56 ACZ# 56 ALGRX 56 pediatric acute lymphoblastic 56 Orphan Status 56 OFIRMEV 56 Angiox 56 Naglazyme 56 Litx 56 metastatic CRC 56 Aclasta 56 humanised monoclonal antibody 56 Trobalt 56 Joulferon 56 ALN VSP 56 Rituxan MabThera 56 HepaSphere 56 inhaled antibiotic 56 Phase IIb clinical trials 56 vinflunine 56 Dynepo 56 L MTP PE 56 IL# PE#QQR 56 Rhucin R 56 tyrosine kinase inhibitor 55 ZEVALIN 55 Renagel ® 55 refractory APL 55 Oncotype DX colon cancer 55 Pradefovir 55 pegylated interferon alpha 55 denosumab 55 ASA# 55 Tasigna nilotinib 55 lenalidomide Revlimid R 55 Vectibix 55 Besivance 55 ZEVALIN ® 55 Exalgo TM 55 lorvotuzumab mertansine 55 masitinib 55 Zalbin 55 Aplidin 55 REVLIMID 55 Brilique 55 BrachySil 55 Xiaflex 55 ELIQUIS 55 post menopausal osteoporosis 55 Cimzia ® certolizumab pegol 55 Oxaliplatin 55 Alocrest 55 Retacrit 55 miconazole Lauriad 55 cannabinor 55 luliconazole 55 novel VDA molecule 55 Synvisc ONE 55 antiangiogenic drugs 55 SomatoKine 55 SEPET TM 55 Multiferon ® 55 relapsed refractory multiple myeloma 55 confirmatory Phase III 55 APOPTONE 55 IV APAP 55 Arixtra 55 ONCONASE R 55 KIACTA ™ 55 midstage trials 55 Panitumumab 55 initiate Phase 1b 55 Tarvacin TM 55 dirucotide MBP# 55 Genentech Herceptin 55 Sensipar 55 RIGScan CR 55 Eraxis 55 ASONEP 55 FUSILEV 55 Tracleer r 55 fesoterodine 55 DCVax ® Brain 55 Gattex 55 KRN# 55 CMV disease 55 Evicel 55 Ranexa 55 fidaxomicin 55 Onsolis 55 MORAb 55 Somatuline R Autogel R 55 MACUGEN 55 Clavis Pharma 55 Denosumab 55 Li Fraumeni Syndrome 55 Preotact R 55 canakinumab 55 SPRYCEL ® 55 anticancer compound 55 non metastatic osteosarcoma 55 taliglucerase alfa 55 Camptosar ® 55 Prednisporin 55 Natalizumab 55 IIa trial 55 immunosuppressant 55 Xolegel 55 vilazodone 55 Lialda 55 ISTODAX 55 Dasatinib 55 Tracleer ® 55 Glypromate 55 Sapien valve 55 GRN# 55 initiate Phase IIb 55 GED aPC 55 durable remissions 55 Pruvel 55 aflibercept 55 paclitaxel Taxol R 55 Iluvien TM 55 Pixuvri 55 Rhucin ® 55 bardoxolone 55 CIMZIA TM 55 CAELYX 55 PerClot 55 blinatumomab 55 Carticel 55 HCD# [002] 55 CRMD# 55 InterStim Therapy 55 GAMMAGARD 55 Stelara 55 PhosLo 55 PNP inhibitor 55 relapsed leukemia 55 OMP #M# 55 sipuleucel T 55 mipomersen 55 BLA submission 55 TNFerade 55 Zenvia ™ 55 OMP designation 55 Yondelis 55 Egrifta 55 Tracleer R 55 picoplatin 55 nonclinical studies 55 Amgen Vectibix 55 RECOTHROM 55 ceftobiprole 55 OrCel R 55 oritavancin 55 Clonicel 55 HuMax EGFr 55 DR Cysteamine 55 Vilazodone 55 Peginterferon alfa 2b 55 bevacizumab Avastin ® 55 Erlotinib 55 ZADAXIN 55 metastatic sarcoma 55 BCR ABL inhibitor 55 pitavastatin 55 AeroLEF TM 55 GALNS 55 SinuNase 55 Biologics License Application BLA 55 gastrointestinal stromal tumors GIST 55 macitentan 55 Quinamed 55 Aurograb 55 perifosine 55 otelixizumab 55 lucinactant 55 CA4P 55 DexaSite 55 Sumavel DosePro 55 JANUVIA 55 gefitinib Iressa 55 Millennium Velcade 55 telaprevir 55 Factor Xa inhibitor 55 TAXUS TM 55 pafuramidine 55 PXD# 55 SAR# [004] 55 GW# [003] 55 imatinib Gleevec ® 55 Lixivaptan 55 subcutaneously administered 55 Interferon alpha 55 TRANSDUR Sufentanil 55 Phase 1b clinical 55 LCP Tacro 55 Adlea 55 haematologic malignancies 55 cell lymphoma CTCL 55 ATPace TM 55 Romidepsin 55 Blinatumomab 55 Soliris 55 darusentan 55 dasatinib Sprycel ® 55 Phase #b/#a 55 brentuximab vedotin 55 Cerashield 55 Eribulin 55 rNAPc2 55 Kit CD# positive 55 Fentanyl Taifun 55 Esbriet pirfenidone 55 zalutumumab 55 Neulasta R 55 PRT# 55 Trovax 55 retigabine 55 INCB# [002] 55 superficial bladder cancer 55 Prosaptide 55 PSN# [001] 55 pivotal Phase III 55 Toraymyxin TM 55 relapsing multiple sclerosis 55 Onalta 55 Aloxi R 55 previously untreated follicular 55 Heplisav 55 CORTOSS 55 Cethromycin 55 frovatriptan 55 pediatric Crohn disease 55 Lodotra 55 Nabi HB 55 eprodisate Fibrillex TM 55 Ozarelix 55 Initiate Clinical Trial 55 Metricath Gemini 55 Byetta LAR 55 ThromCat 55 mapatumumab 55 Cetuximab Erbitux 55 Aloxi 55 LEP ETU 55 BHT DNA 55 Phase III trials 55 BRAF V# mutation 55 Orphan designation 55 BEMA TM Fentanyl 55 Ventavis 55 SUMAVEL 55 Metformin GR 55 Xgeva 55 OMNARIS HFA 55 successfully commercialize Iluvien 55 ZACTIMA 55 Proleukin 55 MAXY G# 55 adjuvant colon cancer 55 gepirone ER 55 RSD# 55 radiotherapeutic 55 torezolid phosphate 55 ATL# [001] 55 temsirolimus 55 Aflibercept 55 teduglutide